Drugs / Danshu Capsules
last change Feb 2018 re-read 2 minutes ago

Danshu Capsules

Developed for
biliary dyskinesia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02833103 Comparator Jul 2016 → Feb 2018 biliary dyskinesia Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danshu Capsules ClinicalTrials.gov intervention name — accepted as the source's own label NCT02833103
Route Oral “Danshu Capsules (0.9g potid/day) for three months by oralNCT02833103